24.10.2022 - New Partnership will Improve and Advance CING Manufacturing OperationsKANSAS CITY, Kan., Oct. 24, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug . Seite 1
Shanej-schaffer
David-enloe
Cingulate-chairman
20.10.2022 - Agreements Showcase Company’s Ability to Support Novel Therapeutic Programs Regardless of Development Stage; Services Focused on Both Preclinical and Last Clinical-Stage ProgramsSAN DIEGO and GAINESVILLE, Ga., Oct. 20, 2022 (GLOBE NEWSWIRE) - . Seite 1
United-states
Canada
David-enloe
Clinical-trial-services